Neue Entwicklungen in der ambulanten parenteralen Antibiotikatherapie (APAT)
暂无分享,去创建一个
[1] S. Hagel,et al. Antibiotikatherapie (2): Ambulante parenterale Gabe , 2019, Deutsches Aerzteblatt Online.
[2] G. Allison,et al. 2018 Infectious Diseases Society of America Clinical Practice Guideline for the Management of Outpatient Parenteral Antimicrobial Therapy. , 2018, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[3] I. Baumann,et al. S3-Leitlinie: Lungenerkrankung bei Mukoviszidose – Modul 2: Diagnostik und Therapie bei der chronischen Infektion mit Pseudomonas aeruginosa , 2018, Pneumologie.
[4] L. Scudeller,et al. Infectious Diseases Team for the Early Management of Severe Sepsis and Septic Shock in the Emergency Department , 2017, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[5] M. Olsen,et al. Impact of Infectious Diseases Consultation on Mortality of Cryptococcal Infection in Patients Without HIV , 2016, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[6] S. Rieg,et al. Infectious diseases consultations can make the difference: a brief review and a plea for more infectious diseases specialists in Germany , 2016, Infection.
[7] D. Nathwani,et al. Good practice recommendations for outpatient parenteral antimicrobial therapy (OPAT) in adults in the UK: a consensus statement. , 2012, The Journal of antimicrobial chemotherapy.
[8] Brett H. Heintz,et al. Impact of a Multidisciplinary Team Review of Potential Outpatient Parenteral Antimicrobial Therapy Prior to Discharge from an Academic Medical Center , 2011, The Annals of pharmacotherapy.
[9] C. Vogelmeier,et al. [Perspectives 2025 - Positions of the German Society of Internal Medicine]. , 2019, Deutsche Medizinische Wochenschrift.
[10] T. Welte,et al. [Perspectives of infectious diseases in Germany]. , 2015, Deutsche medizinische Wochenschrift.